Search research articles
Contact Us
Filters
Showing results (81-90 of 106) with videos related to
Page
of 11
Sort By:
Transplantation and Cellular Therapy
|
November 1, 2023
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation
Lacey S Williams, Kirsten M Williams, Nancy Gillis, et al.
American Journal of Hematology
|
January 6, 2023
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia
Guru Subramanian Guru Murthy, Brent R Logan, Stephanie Bo-Subait, et al.
Blood Advances
|
June 24, 2025
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL
Rakesh Awasthi, Stephan A Grupp, Edward R Waldron, et al.
Blood Advances
|
October 6, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide
Dipenkumar Modi, Yosra M Aljawai, Todd E DeFor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors
Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, et al.
The Journal of Clinical Investigation
|
April 5, 2017
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease
Danny W Bruce, Heather E Stefanski, Benjamin G Vincent, et al.
Bone Marrow Transplantation
|
March 5, 2024
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Anna Sureda, Paul A Carpenter, Andrea Bacigalupo, et al.
Bone Marrow Transplantation
|
June 21, 2024
Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Anna Sureda, Paul A Carpenter, Andrea Bacigalupo, et al.
Blood Cancer Discovery
|
January 12, 2022
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia
Michael A Pulsipher, Xia Han, Shannon L Maude, et al.
The Lancet. Haematology
|
July 28, 2022
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues
Nina Worel, Mahmoud Aljurf, Chloe Anthias, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 106) with videos related to
Sort By:
Page
of 11
Transplantation and Cellular Therapy
|
November 1, 2023
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation
Lacey S Williams, Kirsten M Williams, Nancy Gillis, et al.
American Journal of Hematology
|
January 6, 2023
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia
Guru Subramanian Guru Murthy, Brent R Logan, Stephanie Bo-Subait, et al.
Blood Advances
|
June 24, 2025
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL
Rakesh Awasthi, Stephan A Grupp, Edward R Waldron, et al.
Blood Advances
|
October 6, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide
Dipenkumar Modi, Yosra M Aljawai, Todd E DeFor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors
Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, et al.
The Journal of Clinical Investigation
|
April 5, 2017
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease
Danny W Bruce, Heather E Stefanski, Benjamin G Vincent, et al.
Bone Marrow Transplantation
|
March 5, 2024
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Anna Sureda, Paul A Carpenter, Andrea Bacigalupo, et al.
Bone Marrow Transplantation
|
June 21, 2024
Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Anna Sureda, Paul A Carpenter, Andrea Bacigalupo, et al.
Blood Cancer Discovery
|
January 12, 2022
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia
Michael A Pulsipher, Xia Han, Shannon L Maude, et al.
The Lancet. Haematology
|
July 28, 2022
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues
Nina Worel, Mahmoud Aljurf, Chloe Anthias, et al.
Page
of 11